Scott L. Rauch, MD
President, Psychiatrist in Chief, and Rose-Marie and Eijk van Otterloo Chair of Psychiatry
- Professor of Psychiatry
- Chair, Behavioral and Mental Health
Scott L. Rauch, MD, is president, psychiatrist in chief, and Rose-Marie and Eijk van Otterloo Chair of Psychiatry at McLean Hospital. He is also professor of psychiatry at Harvard Medical School as well as chair of Mass General Brigham Behavioral and Mental Health. Dr. Rauch is past president and current secretary of the Society of Biological Psychiatry and was recently elected to membership of the National Academy of Medicine. He has also served in leadership roles for the Anxiety and Depression Association of America as well as the National Network of Depression Centers.
His principal research interests relate to neuroimaging and the neurobiology of affective disorders. Dr. Rauch and colleagues have been leaders in delineating the neurocircuitry of anxiety disorders as well as pioneers in using modern technology, including brain stimulation, neurosurgery, and internet-based methods, to develop novel treatments for anxiety and mood disorders. Dr. Rauch has won numerous awards for his mentorship and research accomplishments, including from Harvard Medical School, the American Psychiatric Association, and the American College of Neuropsychopharmacology.
Education & Training
- 1982 BA in Neuroscience, Amherst College
- 1987 MD, University of Cincinnati College of Medicine
- 1987-1988 Resident in Internal Medicine, The Jewish Hospital
- 1988-1991 Resident in Psychiatry, Massachusetts General Hospital
- 1990-1991 Chief Resident in Psychiatry, Bulfinch Inpatient Unit, Massachusetts General Hospital
- 1984 Neurobiology Research Training Fellow, University of Cincinnati College of Medicine
- 1988-1991 Clinical Fellow in Psychiatry, Harvard Medical School
- 1991-1993 Ciba Research Fellow in Psychiatry, Obsessive Compulsive Disorders Unit, Massachusetts General Hospital
- 1992-1994 National Cancer Institute Fellow in Radiological Sciences: PET Technologies and Applications, Division of Nuclear Medicine, Massachusetts General Hospital
- 1994-1996 Clinical Investigator Training Program: Harvard/MIT Division of Health Sciences and Technology - Beth Israel Hospital, in collaboration with Pfizer, Inc.
- 1989 Medical License, Board of Registration in Medicine, Commonwealth of Massachusetts
- 1992 Psychiatry, American Board of Psychiatry and Neurology